Loading...
When to Stop Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia
Strict criteria for when to stop tyrosine kinase inhibitor (TKI) therapy in clinical practice are not easily defined without an agreement on what probability of achieving a treatment-free remission (TFR) constitutes a medically acceptable standard and consideration of the potential medical risks of...
Saved in:
| Published in: | Curr Treat Options Oncol |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer US
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5842492/ https://ncbi.nlm.nih.gov/pubmed/29520446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-018-0532-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|